These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14707031)

  • 21. CYP2C9 gene and susceptibility to major depressive disorder.
    LLerena A; Berecz R; Dorado P; González AP; Peñas-LLedó EM; De La Rubia A
    Pharmacogenomics J; 2003; 3(5):300-2. PubMed ID: 14583800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonsteroidal anti-inflammatory drugs and acute upper gastrointestinal bleeding: a prospective study.
    Agrawal NM; Patel R; Mahatma M; Dajani EZ
    J Assoc Acad Minor Phys; 1991; 2(2):64-6. PubMed ID: 1810582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CYP2C9 polymorphisms: considerations in NSAID therapy.
    Ali ZK; Kim RJ; Ysla FM
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):108-14. PubMed ID: 19152219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: a case-control study.
    Figueiras A; Estany-Gestal A; Aguirre C; Ruiz B; Vidal X; Carvajal A; Salado I; Salgado-Barreira A; Rodella L; Moretti U; Ibáñez L;
    Pharmacogenet Genomics; 2016 Feb; 26(2):66-73. PubMed ID: 26544900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention.
    Samowitz WS; Wolff RK; Curtin K; Sweeney C; Ma KN; Andersen K; Levin TR; Slattery ML
    Clin Gastroenterol Hepatol; 2006 Jul; 4(7):894-901. PubMed ID: 16797247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on the pharmacogenomics of NSAID metabolism and the risk of gastrointestinal bleeding.
    Macías Y; Gómez Tabales J; García-Martín E; Agúndez JAG
    Expert Opin Drug Metab Toxicol; 2020 Apr; 16(4):319-332. PubMed ID: 32187502
    [No Abstract]   [Full Text] [Related]  

  • 27. Nonsteroidal antiinflammatory drugs and risk of gastrointestinal bleeding among patients on hemodialysis.
    Jankovic SM; Aleksic J; Rakovic S; Aleksic A; Stevanovic I; Stefanovic-Stoimenov N; Radosavljevic M; Kostic M; Tesic D; Petrovic B
    J Nephrol; 2009; 22(4):502-7. PubMed ID: 19662606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NSAIDs are a significant risk factor for colonic diverticular hemorrhage in elder patients: evaluation by a case-control study.
    Tsuruoka N; Iwakiri R; Hara M; Shirahama N; Sakata Y; Miyahara K; Eguchi Y; Shimoda R; Ogata S; Tsunada S; Sakata H; Fujimoto K
    J Gastroenterol Hepatol; 2011 Jun; 26(6):1047-52. PubMed ID: 21198829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical consequences of cytochrome P450 2C9 polymorphisms.
    Kirchheiner J; Brockmöller J
    Clin Pharmacol Ther; 2005 Jan; 77(1):1-16. PubMed ID: 15637526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms in genes encoding acetylsalicylic acid metabolizing enzymes are unrelated to upper gastrointestinal health in cardiovascular patients on acetylsalicylic acid.
    van Oijen MG; Huybers S; Peters WH; Drenth JP; Laheij RJ; Verheugt FW; Jansen JB
    Br J Clin Pharmacol; 2005 Dec; 60(6):623-8. PubMed ID: 16305586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk.
    Bigler J; Whitton J; Lampe JW; Fosdick L; Bostick RM; Potter JD
    Cancer Res; 2001 May; 61(9):3566-9. PubMed ID: 11325819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin-induced peptic ulcer and genetic polymorphisms.
    Shiotani A; Sakakibara T; Nomura M; Yamanaka Y; Nishi R; Imamura H; Tarumi K; Kamada T; Hata J; Haruma K
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S31-4. PubMed ID: 20586862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VKORC1-1639 G>A Polymorphism and the Risk of Non-Variceal Upper Gastrointestinal Bleeding.
    Groza I; Matei D; Tantau M; Trifa AP; Crisan S; Vesa SC; Bocsan C; Buzoianu AD; Acalovschi M
    J Gastrointestin Liver Dis; 2017 Mar; 26(1):13-18. PubMed ID: 28338108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapy.
    Peyvandi F; Spreafico M; Siboni SM; Moia M; Mannucci PM
    Clin Pharmacol Ther; 2004 Mar; 75(3):198-203. PubMed ID: 15001971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms of human cytochrome P450 2C9 and the functional relevance.
    Zhou SF; Zhou ZW; Huang M
    Toxicology; 2010 Dec; 278(2):165-88. PubMed ID: 19715737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Nonvariceal upper gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drugs in Metropolitan Lima].
    Salvatierra Laytén G; de la Cruz Romero L; Paulino Merino M; Vidal Vidal V; Rivera Dávila C; Cano Chuquilin A; Frisancho Velarde O
    Rev Gastroenterol Peru; 2006; 26(1):13-20. PubMed ID: 16622483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytochrome P450 2C9 polymorphism and acenocoumarol therapy.
    Mark L; Marki-Zay J; Fodor L; Hajdara I; Paragh G; Katona A
    Kardiol Pol; 2006 Apr; 64(4):397-402; discussion 403-4. PubMed ID: 16699986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of cytochrome P450 2C9 polymorphisms on phenprocoumon anticoagulation status.
    Schalekamp T; Oosterhof M; van Meegen E; van Der Meer FJ; Conemans J; Hermans M; Meijerman I; de Boer A
    Clin Pharmacol Ther; 2004 Nov; 76(5):409-17. PubMed ID: 15536456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NSAIDs increase risk of gastrointestinal bleeding in primary care patients with dyspepsia.
    Kurata JH; Nogawa AN; Noritake D
    J Fam Pract; 1997 Sep; 45(3):227-35. PubMed ID: 9300002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5-HTTLPR-S) and the CYP2C9*3 allele.
    Dorado P; Peñas-Lledó EM; González AP; Cáceres MC; Cobaleda J; Llerena A
    Fundam Clin Pharmacol; 2007 Aug; 21(4):451-3. PubMed ID: 17635185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.